Insulet data shows Omnipod 5's superiority to regular pump therapy
Mar 8, 2024 · Results demonstrated significantly lower mean glucose and time above 180 mg/dL in the Omnipod 5 group. That group also spent significantly less time below 70 mg/dL. Mean time decreased from 1.66% to 1.18% with Omnipod 5, compared to an increase from 1.66% to 1.75% in the control group. Time below 54 mg/dL proved non-inferior between groups.
The 9 largest diabetes technology companies in the world
Aug 21, 2024 · 1. Abbott Diabetes Care — 2023 revenue: $5.761B. Abbott, one of the world’s largest medtech companies in a broader sense, takes the top spot in diabetes, too. The company’s Diabetes Care unit brought in more than $2 billion more than any other company on this list. With its Diabetes Care unit located in Alameda, California, Abbott ...
Insulet fully launches Omnipod 5 with Dexcom G7 in the U.S.
Jun 20, 2024 · Omnipod 5, the first FDA-cleared tubeless automated insulin delivery system, communicates with a CGM. It proactively corrects for highs and protects against lows with insulin dosing. The waterproof device features mobile app control for ease of use. Acton, Massachusetts-based Insulet began a limited rollout of Omnipod 5 with G7 earlier this year.
Abbott, Medtronic partner to connect CGM, insulin delivery systems
Aug 7, 2024 · Left: the Abbott FreeStyle Libre 3 CGM. Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing Abbott CGMs with Medtronic insulin delivery systems. The partnership aims to collaborate on a system based on Abbott’s FreeStyle Libre continuous glucose monitors (CGMs) with Medtronic’s ...
Medtronic wins CE mark for MiniMed 780G with Simplera Sync
Jan 8, 2024 · The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received CE mark approval for its MiniMed 780G system with Simplera Sync. Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM), eliminates the need for fingersticks and overtape.
Dexcom announces direct-to-watch feature for G7 CGM
Mar 5, 2024 · The ONE+ system, featuring a sensor, reader, smartphone, smartwatch and applicator. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced today that it introduced a direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users. The company plans a phased launch for all G7 iOS users everywhere by the end of the second quarter of this year.
Dexcom CEO explains plans for Stelo CGM, G7 and beyond
Jun 23, 2024 · The Stelo glucose monitor. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) CEO Kevin Sayer says the prospect of an over-the-counter CGM made him and other company leaders uneasy. When the company first began planning a glucose monitor for the type 2 diabetes population not using insulin, there were questions about reimbursement, the impact of GLP-1 drugs and other causes for concern.
FDA approves next-gen drug delivery system from Medtronic
October 10, 2023 By Sean Whooley. The SynchroMed III system. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity.
Vero Biotech raises $30M for tankless nitric oxide delivery system
January 11, 2023 By Sean Whooley. [Image courtesy of Vero Biotech] Vero Biotech announced today that it raised $30 million to support its Genosyl inhaled nitric oxide (iNO) delivery system. The financing comes just days after the company received FDA approval for Genosyl. The third-generation Genosyl delivery system features faster dosing ...
Tandem Diabetes Care launches Mobi automated insulin pump
Feb 13, 2024 · The Mobi miniature, durable automated insulin patch pump worn on a hiker’s leg. [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that it kicked off the U.S. commercial launch of its Mobi insulin patch pump. The San Diego-based company says Mobi, which is fully controllable from a mobile app, is the world’s smallest durable automated insulin ...